Home › Funds › Sio Capital Management, LLC › ALGS

Sio Capital Management, LLC position in ALGS

ALIGOS THERAPEUTICS · Health Care

Sio Capital Management, LLC reported holding 327,237 shares of ALGS (ALIGOS THERAPEUTICS) in its Q2 2026 13F filing — a position valued at US$1.9M, representing 0.31% of its reported portfolio and ranking #47 among its reported holdings. Sio Capital Management, LLC has disclosed ALGS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)327.24K sh
Reported value held$1.89M
Portfolio Weight0.31%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sio Capital Management, LLC's ALGS position evolved

Sio Capital Management, LLC first disclosed a stake in ALGS in Q1 2025 at 180,720 shares (US$1.5M). The position peaked in Q3 2025 at 335,937 shares, worth US$3.3M. Across 6 filings, Sio Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 327,237 shares valued at US$1.9M. Notable position changes include a 86% increase in Q2 2025 (shares rose 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 180.72K $1.49M New
Q2 2025 335.94K $2.42M Add
Q3 2025 335.94K $3.29M Hold
Q4 2025 335.94K $3.13M Hold
Q1 2026 327.24K $2.43M Reduce
Q2 2026 327.24K $1.89M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALGS and 13F data

ALGS (ALIGOS THERAPEUTICS) is a Health Care company. 23 other funds we track also report a position in ALGS — the largest reported positions include Hillhouse Capital (HHLR Advisors) (US$440K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALGS

All ALGS fund holders →

FAQ

How long has Sio Capital Management, LLC held ALGS?

Sio Capital Management, LLC has disclosed ALGS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Sio Capital Management, LLC's current position in ALGS?

As of Q2 2026, Sio Capital Management, LLC holds 327.24K shares of ALGS (ALIGOS THERAPEUTICS), valued at $1.89M, representing 0.31% of its reported portfolio and ranking #47.

Has Sio Capital Management, LLC been buying or selling ALGS?

In the latest 13F filing (Q2 2026), Sio Capital Management, LLC held unchanged its position in ALGS. The position peaked in Q3 2025 at 335.94K shares.

Which other funds hold ALGS?

Other major institutional holders of ALGS include Hillhouse Capital (HHLR Advisors), among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.